Cargando…

Bromido[1-(η(6)-4-tert-butyl­benz­yl)-3-(2,4,6-trimethyl­benz­yl)benzimidazol-2-yl­idene]chloridoruthenium(II)

A new ruthenium complex, [RuBrCl(C(28)H(32)N(2))], has been synthesized and characterized by elemental analysis, (1)H NMR, (13)C NMR, IR-spectroscopy and a single-crystal X-ray diffraction study. The Ru atom in this complex is best described as having a considerably distorted octa­hedral coordinatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Arslan, Hakan, VanDerveer, Don, Özdemir, İsmail, Demir, Serpil, Çetinkaya, Bekir
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967929/
https://www.ncbi.nlm.nih.gov/pubmed/21581560
http://dx.doi.org/10.1107/S1600536808042256
_version_ 1782189728665174016
author Arslan, Hakan
VanDerveer, Don
Özdemir, İsmail
Demir, Serpil
Çetinkaya, Bekir
author_facet Arslan, Hakan
VanDerveer, Don
Özdemir, İsmail
Demir, Serpil
Çetinkaya, Bekir
author_sort Arslan, Hakan
collection PubMed
description A new ruthenium complex, [RuBrCl(C(28)H(32)N(2))], has been synthesized and characterized by elemental analysis, (1)H NMR, (13)C NMR, IR-spectroscopy and a single-crystal X-ray diffraction study. The Ru atom in this complex is best described as having a considerably distorted octa­hedral coordination environment with the arene occupying three coordination sites. Two further coordination sites are occupied by chloride and bromide ligands, while the sixth site is occupied by the carbene. The carbene portion of the ligand is a benzimidazole ring. This ring is connected to the C(6)H(4)C(CH(3))(3) arene by a CH(2) bridge. This leads to a system with very little apparent strain. The two halogen atoms are disordered between Br and Cl. Two partial Cl atoms share the same sites as two partial Br atoms so that the title compound effectively has one Cl and one Br atom. C—H⋯X (X = Cl, Br) hydrogen bonds help to stabilize the crystal structure.
format Text
id pubmed-2967929
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-29679292010-12-30 Bromido[1-(η(6)-4-tert-butyl­benz­yl)-3-(2,4,6-trimethyl­benz­yl)benzimidazol-2-yl­idene]chloridoruthenium(II) Arslan, Hakan VanDerveer, Don Özdemir, İsmail Demir, Serpil Çetinkaya, Bekir Acta Crystallogr Sect E Struct Rep Online Metal-Organic Papers A new ruthenium complex, [RuBrCl(C(28)H(32)N(2))], has been synthesized and characterized by elemental analysis, (1)H NMR, (13)C NMR, IR-spectroscopy and a single-crystal X-ray diffraction study. The Ru atom in this complex is best described as having a considerably distorted octa­hedral coordination environment with the arene occupying three coordination sites. Two further coordination sites are occupied by chloride and bromide ligands, while the sixth site is occupied by the carbene. The carbene portion of the ligand is a benzimidazole ring. This ring is connected to the C(6)H(4)C(CH(3))(3) arene by a CH(2) bridge. This leads to a system with very little apparent strain. The two halogen atoms are disordered between Br and Cl. Two partial Cl atoms share the same sites as two partial Br atoms so that the title compound effectively has one Cl and one Br atom. C—H⋯X (X = Cl, Br) hydrogen bonds help to stabilize the crystal structure. International Union of Crystallography 2008-12-20 /pmc/articles/PMC2967929/ /pubmed/21581560 http://dx.doi.org/10.1107/S1600536808042256 Text en © Arslan et al. 2009 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Metal-Organic Papers
Arslan, Hakan
VanDerveer, Don
Özdemir, İsmail
Demir, Serpil
Çetinkaya, Bekir
Bromido[1-(η(6)-4-tert-butyl­benz­yl)-3-(2,4,6-trimethyl­benz­yl)benzimidazol-2-yl­idene]chloridoruthenium(II)
title Bromido[1-(η(6)-4-tert-butyl­benz­yl)-3-(2,4,6-trimethyl­benz­yl)benzimidazol-2-yl­idene]chloridoruthenium(II)
title_full Bromido[1-(η(6)-4-tert-butyl­benz­yl)-3-(2,4,6-trimethyl­benz­yl)benzimidazol-2-yl­idene]chloridoruthenium(II)
title_fullStr Bromido[1-(η(6)-4-tert-butyl­benz­yl)-3-(2,4,6-trimethyl­benz­yl)benzimidazol-2-yl­idene]chloridoruthenium(II)
title_full_unstemmed Bromido[1-(η(6)-4-tert-butyl­benz­yl)-3-(2,4,6-trimethyl­benz­yl)benzimidazol-2-yl­idene]chloridoruthenium(II)
title_short Bromido[1-(η(6)-4-tert-butyl­benz­yl)-3-(2,4,6-trimethyl­benz­yl)benzimidazol-2-yl­idene]chloridoruthenium(II)
title_sort bromido[1-(η(6)-4-tert-butyl­benz­yl)-3-(2,4,6-trimethyl­benz­yl)benzimidazol-2-yl­idene]chloridoruthenium(ii)
topic Metal-Organic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967929/
https://www.ncbi.nlm.nih.gov/pubmed/21581560
http://dx.doi.org/10.1107/S1600536808042256
work_keys_str_mv AT arslanhakan bromido1ē64tertbutylbenzyl3246trimethylbenzylbenzimidazol2ylidenechloridorutheniumii
AT vanderveerdon bromido1ē64tertbutylbenzyl3246trimethylbenzylbenzimidazol2ylidenechloridorutheniumii
AT ozdemirismail bromido1ē64tertbutylbenzyl3246trimethylbenzylbenzimidazol2ylidenechloridorutheniumii
AT demirserpil bromido1ē64tertbutylbenzyl3246trimethylbenzylbenzimidazol2ylidenechloridorutheniumii
AT cetinkayabekir bromido1ē64tertbutylbenzyl3246trimethylbenzylbenzimidazol2ylidenechloridorutheniumii